Dirk Haasner

No más puestos en curso

61 años

Health Technology

Consumer Services

Perfil

Dirk Haasner is the founder of 4-Antibody AG.
Formerly, VP-Regulatory, Medical Affairs & Policy at Lundbeck USA Inc. from 2002 to 2015.
Senior Vice President-Global Regulatory Affairs at Ovid Therapeutics, Inc. from 2015 to 2022.
Education includes a graduate degree from the University of Basel, conferred in 1991, and a doctorate from the Basel Institute for Immunology, conferred in 1994.

Antiguos cargos conocidos de Dirk Haasner.

Empresas	Cargo	Fin
OVID THERAPEUTICS INC.	Consejero General	-
Lundbeck USA Inc.	Consejero General	01/11/2015
4-Antibody AG 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs	Fundador	-

Ver el detalle de la experiencia de Dirk Haasner.

Formación de Dirk Haasner.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Dirk Haasner.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Ovid Therapeutics, Inc. Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders	Health Technology
4-Antibody AG 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs	Health Technology
University of Basel University of Basel Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Basel Institute for Immunology Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lundbeck USA Inc.